| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Pathology, Duke University Medical Center, Durham 27710; 2 National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709; and 3 Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267
Recent studies suggest a role for phospholamban phosphorylation during ischemia and reperfusion. The role of phospholamban in ischemia was studied by subjecting hearts from male and female wild-type (MWT/FWT) and phospholamban-knockout (MKO/FKO) mice to 20 min of ischemia-40 min of reperfusion while 31P NMR spectra were acquired. ATP and pH values fell lower during ischemia, and postischemic contractility was less, in MKO and FKO versus WT hearts. After shorter ischemia (15 min), recoveries of contraction, ATP, and pH were greater in FKO than MKO hearts. To examine the role of nitric oxide (NO) synthases (NOS) in the protection in FKO versus MKO hearts, we utilized 1 µM L-NAME, a NOS inhibitor, or 100 µM S-nitroso-N-acetylpenicillamine (SNAP), an NO donor. Recoveries of function, ATP, and pH were less in L-NAME-treated FKO than untreated FKO hearts and greater in SNAP-treated MKO than untreated MKO hearts. In conclusion, phospholamban ablation increased ischemic injury in both males and females; however, female hearts were less susceptible than male hearts. Protection in females was decreased by a NOS inhibitor and mimicked in males by an NO donor, implying that protection was NOS mediated.
ischemia; energetics; sarcoplasmic reticulum
This article has been cited by other articles:
|
|
 |
|
  M.A. H. Talukder, J. L. Zweier, and M. Periasamy Targeting calcium transport in ischaemic heart disease Cardiovasc Res, August 17, 2009; (2009) cvp264v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Nicolaou, P. Rodriguez, X. Ren, X. Zhou, J. Qian, S. Sadayappan, B. Mitton, A. Pathak, J. Robbins, R. J. Hajjar, et al. Inducible Expression of Active Protein Phosphatase-1 Inhibitor-1 Enhances Basal Cardiac Function and Protects Against Ischemia/Reperfusion Injury Circ. Res., April 24, 2009; 104(8): 1012 - 1020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Vinge, P. W. Raake, and W. J. Koch Gene Therapy in Heart Failure Circ. Res., June 20, 2008; 102(12): 1458 - 1470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Day, P. Coutu, W. Wang, T. Herron, I. Turner, M. Shillingford, N. C. LaCross, K. L. Converso, L. Piao, J. Li, et al. Cardiac-directed parvalbumin transgene expression in mice shows marked heart rate dependence of delayed Ca2+ buffering action Physiol Genomics, May 1, 2008; 33(3): 312 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tanno and T. Miura Protecting ischemic hearts by modulation of SR calcium handling Cardiovasc Res, August 1, 2007; 75(3): 453 - 454. [Full Text] [PDF]
|
|
|
|
|
|
E. Murphy and C. Steenbergen Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury Cardiovasc Res, August 1, 2007; 75(3): 478 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhou, G.-C. Fan, X. Ren, J. R. Waggoner, K. N. Gregory, G. Chen, W. K. Jones, and E. G. Kranias Overexpression of histidine-rich Ca-binding protein protects against ischemia/reperfusion-induced cardiac injury Cardiovasc Res, August 1, 2007; 75(3): 487 - 497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Thorp, J. V. Haist, J. Leppard, K. J. Milne, M. Karmazyn, and E. G. Noble Exercise training improves myocardial tolerance to ischemia in male but not in female rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R363 - R371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Di Lisa A Female Way to Protect the Heart: Say NO to Calcium Circ. Res., February 17, 2006; 98(3): 298 - 300. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Xie, Y. Zhu, W.-Z. Zhu, L. Chen, Z.-N. Zhou, W.-J. Yuan, and H.-T. Yang Role of dual-site phospholamban phosphorylation in intermittent hypoxia-induced cardioprotection against ischemia-reperfusion injury Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2594 - H2602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Anderson, D. M. Kirkland, A. Beyschau, and P. M. Cala Acute effects of 17{beta}-estradiol on myocardial pH, Na+, and Ca2+ and ischemia-reperfusion injury Am J Physiol Cell Physiol, January 1, 2005; 288(1): C57 - C64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-J. Du Gender modulates cardiac phenotype development in genetically modified mice Cardiovasc Res, August 15, 2004; 63(3): 510 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chen, J. Petranka, K. Yamamura, R. E. London, C. Steenbergen, and E. Murphy Gender differences in sarcoplasmic reticulum calcium loading after isoproterenol Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2657 - H2662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Said, L. Vittone, C. Mundina-Weilenmann, P. Ferrero, E. G. Kranias, and A. Mattiazzi Role of dual-site phospholamban phosphorylation in the stunned heart: insights from phospholamban site-specific mutants Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1198 - H1205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Dorn II, J. Robbins, and P. H. Sugden Phenotyping Hypertrophy: Eschew Obfuscation Circ. Res., June 13, 2003; 92(11): 1171 - 1175. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
